Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare is attractive because its core Personal Care business is showing improving same-store census, solid labor execution, and about a 4% New Mexico rate increase, while management expects 4Q to reach flat to slightly positive census growth. The company also posted 3Q adjusted EBITDA of $51.2M, a 13.2% margin, and strong financial flexibility with $98.5M of cash, $24.3M of debt, and $617.8M of revolver availability, supporting continued investment and M&A. Its outlook is further strengthened by growth in Hospice and Home Health, favorable reimbursement and compliance trends, and a fragmented market that should reward scaled operators with disciplined execution.

Addus HomeCare is exposed to concentrated reimbursement and policy risk, with more than 20% of revenue tied to the Illinois CCP, making any program change disproportionately damaging to financial results. Its core personal care business is vulnerable to state minimum wage increases or lower provider rates without offsetting reimbursement, while Federal Medicaid policy shifts and the Medicaid Access Rule could compress growth and margins, especially where service margins exceed 20%. Further, possible reductions in Medicare hospice and home health reimbursement, along with Gentiva integration challenges, add execution risk and could weigh on projected profitability.